With this notice, the Microorganisms Editorial Office alerts the readers of concerns related to this article []. Following publication, concerns were raised to the Editorial Office regarding the degree in which this study adheres to MDPI’s policies on Research Involving Human Participants (https://www.mdpi.com/ethics#_bookmark9 accessed date: 18 May 2025). The Editor-in-Chief has decided to issue this expression of concern while an investigation is being conducted. The authors’ institution has been contacted to contribute to this investigation.
Once this process has been completed, the Editorial Office will provide an update on the situation and announce any post-publication modifications deemed necessary, as per MDPI’s Update to Published Papers policy (https://www.mdpi.com/ethics#_bookmark30 accessed date: 18 May 2025).
Reference
- Bellomo, A.R.; Rotondi, G.; Rago, P.; Bloise, S.; Di Ruzza, L.; Zingoni, A.; Di Valerio, S.; Valzano, E.; Di Pierro, F.; Cazzaniga, M.; et al. Effect of Bifidobacterium bifidum Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical Trial. Microorganisms 2024, 12, 1093. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).